opgn stock forecast zacks

The analysts previously had rating of Sell. View analysts price targets for OpGen or view top-rated stocks among Wall Street analysts.

Can Fite Biopharma Ltd Canf Stock Price News Quote History Yahoo Finance

OPGN came out with a quarterly loss of 019 per share in line with the Zacks Consensus Estimate.

. Do the numbers hold clues to. During that period the price should oscillate between. On average they expect OpGens stock price to reach 350 in the next twelve months.

OPGN OpGen Stock Price and Discussion Stocktwits. This suggests a possible upside of 2933 from the stocks current price. The Zacks Consensus Estimate for its current year earnings has been revised 19 downward over the last 30 days.

In the short term 2weeks OPGNs stock price should outperform the market by 615. Research for OPGN OPGN 101 -004 -381 Will OPGN be a Portfolio Killer in January. OPGN delivered earnings and revenue surprises of 000 and -2267 respectively for the quarter ended June 2021.

Zacks Consensus Estimate This company is expected to post quarterly loss of 019 per share in its upcoming report which represents a year-over-year change of 525. OpGen has a 1 year low of 096 and a 1 year high of 437. OPGN 087 007 742 Post-Market 001 118 33445.

Their forecasts range from 300 to 400. Stock Market Daily. Zacks Investment Researchs price target indicates a potential upside of 363 from the stocks current price.

The firm currently has a 100 target price on the medical research companys stock. Our latest prediction for Opgen Incs stock price was made on the Nov. OpGen Upgraded by Zacks Investment Research on 10202021.

Youll find the Opgen share forecasts stock quote and buy sell signals belowAccording to present data Opgens OPGN shares and potentially its market environment have been in bearish cycle last 12 months if exists. Today you can download 7 Best Stocks for the Next 30 Days. Is currently rated as a Zacks Rank 2 and we are expecting an above average return from.

This compares to loss of 049 per share a year ago. Opgen Inc Stock Market info Recommendations. Wall Street Stock Market Finance report prediction for the future.

If Id invested 1000 in Barclays shares 5 years ago heres how much. Want the latest recommendations from Zacks Investment Research. Revenues are expected to be.

The company has a debt-to-equity. Zacks proprietary data indicates that OpGen Inc. Stock Exchange NASDAQ Ticker Symbol OPGN Full Company Profile Financial Performance Financial Statements Analyst Forecast According to 2 analysts the average rating for OpGen stock is Buy The 12-month stock price forecast is 350 which is an increase of 27234 from the latest price.

OpGen stock has undergone multiple analysts rating changes in the recent past. Zacks Investment Research is releasing its prediction for OPGN based on. OpGen NASDAQ Updated Jan 22 2022 1257 AM.

OPGN traded down 001 on Friday reaching 099. OpGen had a negative net margin of 82932 and a negative return on equity of 8294. According to Zacks OpGen Inc.

Zacks Investment Research s price target indicates a potential upside of 363 from the stocks current price. Stock Price Forecast The 2 analysts offering 12-month price forecasts for OpGen Inc have a median target of 350 with a high estimate of 400 and a low estimate of 300. Click to get this free report OpGen Inc.

18 2021 when the stock price was at 144. The companys stock had a trading volume of 2788 shares compared to its average volume of 605372. Price Target 350 27234 upside Analyst Consensus.

The stock has a market cap of 3856 million a price-to-earnings ratio of -084 and a beta of -083. OpGen NASDAQOPGN last issued its quarterly earnings results on Thursday November 11th. Buy or sell Opgen stock.

According to Zacks OpGen Inc. In a note to investors the firm issued a new rating of Hold. The medical research company reported 016 earnings per share for the quarter topping the Zacks consensus estimate of 019 by 003.

OPGN is engaged in developing molecular information products and services.

Coronavirus Stocks Companies Impacted By Covid 19

Opgen Price Target Analyst Ratings Nasdaq Opgn

Ocugen Ocgn Stock Forecast Awaiting Regulatory Approval Photo Shutterstock

Bright Scholar Education Holdngs Bedu Downgraded By Zacks Investment Research Tweet Zacks Investment Research Lowered Shares Education Scholar Investing